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ABSTRACT
Background: Spinal haemangioblastomas are rare 
benign but potentially devastating vascular tumours. 
They may occur sporadically or as a component of 
Von Hippel-Lindau (VHL) disease. There is a dearth 
of information on these tumours among Nigerians. 
This study aims to evaluate the clinical profile and 
outcome of surgery as well as the challenges of the 
management of these tumours in a resource-limited 
country.
Methods: We retrospectively analysed data from the 
records of patients who had surgery for spinal 
haemangioblastoma at our centre between January 
2004 and December 2018.
Results: We operated 2 cases of spinal 
haemangioblastomas during the study period (1 
male, 1 female). The patients were aged 25 and 50 
years. 
 The onset of symptoms was 
2 weeks in one patient and 18 months in the other. 
The tumour was located in the thoracic region in the 
2 patients. One patient had extramedullary tumour
. Both 
individuals were paraplegic at the time of surgery, 
which was 3 days in one patient and more than 4 
months in the other. Whereas gross total tumour 
resection was achieved  patient 
with shorter duration of symptoms and 
While both patients had thoracic lesions and 
presented with sensorimotor deficits, only one had 
sphincteric dysfunction.
  
patient had an intramedullary tumour location
both instances, the
extramedullary tumour made a rapid-post operative 
neurological improvement, while the one with the 
longer duration of symptoms and intramedullary 
tumour remained paraplegic until his death nine 
months after surgery.
Conclusion: Spinal haemangioblastomas are rare 
tumours. Long duration of symptoms and 
intramedullary tumour location may be predictors of 
unfavorable surgical outcome.
INTRODUCTION
Haemangioblastomas are benign vascular tumours 
of the central nervous system, CNS (1, 2, 3, 4). They 
may occur sporadically (75%) or as a component of 
Von Hippel-Lindau (VHL) disease (25%) (1). 
Common locations in the CNS include the 
cerebellum (44%–72%), spinal cord (13%–50%), 
brainstem (10%–20%), supratentorial region (<1%), 
and lumbosacral nerve roots (<1%) (5). Spinal cord 
haemangioblastomas are relatively rare, accounting 
for only 2% to 6% of all spinal cord tumors (1, 6). In 
spite of their benign nature, they can result in 
clinically devastating morbidities to the affected 
patients due to severe neurological deficits resulting 
from tumour mass, perilesional oedema, cyst or 
syrinx (1, 3, 4, 7). There is a paucity of information 
on  sp ina l  tumours ,  par t icu la r ly  sp ina l  
haemangioblastomas, in Sub-Saharan Africa. We 
present a report of two cases of sporadic spinal 
haemangioblastomas in Nigerian patients. To the 
best of our knowledge, this is the first report on these 
tumours from our country.
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Case reports
Case 1:
25-year-old right-handed female who presented 
with right flank pain, numbness and paraesthesia of 
the lower extremities of two weeks' duration. She 
developed progressive paraparesis about ten days 
later. Her symptoms were not associated with 
sphincteric dysfunction. Examination revealed full 
power in the upper extremities. She however had a 
spastic paraparesis which was significantly worse 
on the right (grade 1-3), hyperreflexia (worse in the 
lower limbs) and sustained ankle clonus bilaterally. 
Her plantar response was extensor on the right and 
flexor on the left. She had a sensory level of T9. 
There were no features suggestive of VHL. 
Magnetic resonance imaging of the thoracic spine 
showed a T10 intradural-extramedullary lesion 
(Figure 1 a-c). She had further neurologic 
deterioration (from Frankel C to B) a week after 
presentation while sourcing for funds for her care. 
She subsequently had (part ial)  T9/T10 
laminectomies and gross total tumour excision. Her 
post-surgery recovery was satisfactory with 
progressive improvement in motor functions of the 
lower limbs. She was discharged 
 with lower limb 
+power of grade 4 to 4 . On follow-up evaluation five 
weeks post-operatively, she had full muscle power 
in the lower limb muscle groups, except for the hip 
and knee 
. At six months follow-up, she had 
regained full power in all the muscle groups of the 
lower extremities. Histology was in keeping with a 
capillary haemangioblastoma. 
home twenty two 
days after surgical intervention
-extensors which were grade 4 to 4  
bilaterally
Case 2:
50-year-old right-handed man who presented with 
low back pain and progressive paraparesis of 
eighteen months and three months duration 
respectively. He had no co-morbidities. 
Examination revealed a middle-aged man with 
normal general examination findings. His long 
tracts were normal in the upper limbs. He had a 
- + spastic paraparesis with power being grade 4 to 4 in 
the right lower limb and 4 to 5 in the left lower limb. 
Sensory level was T7 bilaterally with residual to S4 
and S5. Magnetic resonance imaging of the thoracic 
spine revealed a T9/T10 contrast-enhancing 
intramedullary tumour (Fig. 2). 
Fig. 2: Sagittal T1 (a) and T1+C (b) thoracic spine magnetic 
resonance imaging of patient 2 showing a T9/T10 contrast 
enhancing intramedullary tumour (arrow)
The patient initially declined surgical treatment and 
presented two months later with paraplegia, 
complete loss of sensation in the lower limbs, 
bisphincteric incontinence, infected grade IV mid-
sacral decubitus ulcer and systemic evidence of 
sepsis. He had wound debridement and broad-
spectrum intravenous antibiotic therapy. Following 
resolution of sepsis a month later, he had a T8-T10 
laminectomies and gross total tumour excision (Fig. 
3). Histology revealed a haemangioblastoma (Fig. 
4). He made no neurologic gains post-operatively 
and was discharged home after five months of 
hospitalisation following healing of his pressure 
Fig. 1: Sagittal T1+C (a), T2+C (b) and coronal T1+C 
thoracic spine magnetic resonance imaging of patient 1 
showing a contrast-enhancing T10 intradural-
extramedullary tumour (arrows)
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sore. He was however readmitted three months later 
due to multiple bed sores (including a grade IV 
recurrent infected mid-sacral pressure ulcer) and 
septic shock. There was repetitive faecal soilage of 
the ischial component of the bedsores with waxing 
and waning systemic sepsis throughout his 
hospitalisation. The patient refused a colostomy. He 
developed multiple-organ dysfunction terminally 
and died nine months post-operatively.
Fig. 3: Intraoperative photograph of the second patient after 
T8-T10 laminectomies and a durotomy. Note the purplish 
discoloration of the spinal cord at the site of the tumour 
(lower arrow). The upper arrow is on the dural edge and the 
arrow heads are on the cord proximal and distal to the 
lesion.
Fig. 4: Photomicrograph of the second patient showing 
proliferating stroma cells, tumour cells with oval to spindle 
shaped nuclei, occasional tumour giant cells and multiple 
thin-walled vascular channels (a-×25, b- ×40).
DISCUSSION
Spinal haemangioblastomas are relatively rare 
tumours accounting for 2-6% of spinal cord tumours 
(6, 8). They may occur sporadically or as part of 
VHL syndrome (1). Although histologically benign, 
these tumours can cause significant neurological 
deficits because of their location (1, 3, 4, 7). Between 
January 2004 and December 2018, we operated 2 
patients with spinal haemangioblastoma, accounting 
for 2.1% of the operated cases of spinal tumours in 
our centre during the period. This is in keeping with 
the reported incidence of these tumours (6).
Male predominance of spinal haemangioblastomas 
has been documented, with a reported male to female 
ratio ranging between 1.6:1 to 5.5:1 (3, 8, 9, 10, 11, 
12). The male gender accounted for 72.7% of the 
cases in the series by Yasuda et al (8) and 75% of the 
case in the series by Park et al (12). Conversely, there 
were more females in the study by Das et al with the 
male gender accounting for 42.9% of the patients' 
population (1). Our patients were equally distributed 
b e t w e e n  t h e  t w o  g e n d e r s .  S p i n a l  
haemangioblastomas commonly occur in the third 
and fourth decades of life although occurrences in 
patients on either sides of this age range have been 
documented (1, 8, 12). The average age was 33.5 
years in the series by Das et al (1) and 53.9 years in 
the series by Yasuda et al (8). The younger of our 
patients was in the third decade of life while the older 
one was in the sixth decade. 
These tumours may present clinically with motor, 
sensory or autonomic deficits. In the series by Das et 
al (1) motor weakness was present in 86% of the 
patients at presentation, sensory deficits in 79% and 
bladder disturbance in 21%. Pain was the presenting 
symptom in 29% of their patients. Motor weakness 
and sensory deficits were the most common 
presenting symptoms in the study by Park et al (12) 
each occurring in 50% of the cases. Our patients had 
sensorimotor deficits at presentation but sphincteric 
dysfunction was present in only one of them.
Spinal haemangioblastomas are primarily intradural 
tumours and occur mostly in the cervical and 
thoracic regions (1, 3, 8, 13, 14, 15). In the series by 
Imagama et al (14) 84.6% of the tumours were 
i n t r a m e d u l l a r y ,  1 1 . 5 %  w e r e  
intramedullary/extramedullary, and 3.8% were 
intradural-extramedullary. Deng et al (13) reported 
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41%, 37%, and 22%, respectively for the same 
groups of  tumours respectively. In our patients the 
tumours were located in the thoracic region. The 
tumour was intramedullary in one patient and 
intradural-extramedullary in the other. Patients with 
intradural-extramedullary haemangioblastomas 
tend to be older than the patients with 
intramedullary tumours (8, 11, 16, 17, 18, 19, 20). 
Contrariwise, the younger of our patients had an 
intradural-extramedullary tumour location, 
whereas in the older one, the tumour location was 
intramedullary. 
Microsurgical resection remains the treatment of 
choice for spinal haemangioblastomas but 
radiosurgery has been used in some patients (15, 21, 
22, 23, 24, 25). The outcome of surgical 
management of these tumours depends on the pre-
operative neurological status of the patients, 
location / volume of the tumour, duration of 
symptoms and the extent of surgical resection (1, 2, 
4, 12, 26, 27, 28, 29). Good pre-operative functional 
status, complete tumour excision, small size and 
dorsal tumour location are predictors of good post-
operative outcome. Our 2 patients were paraplegic 
at the time of surgery, the first for about 3 days and 
the second for more than 4 months. They both had 
gross total resection of their tumours. The duration 
of symptoms was significantly shorter in the patient 
with post-operative neurological improvement who 
also happened to be the one with an  intradural-
extramedullary tumour.
Our cases also highlighted the role of poverty, 
ignorance, and lack of social support in the outcome 
of neurological diseases in resource-poor countries. 
The first of our patients became paraplegic while 
sourcing for funds for surgery while the second 
patient (although better educated than the first 
patient) initially declined surgery. He returned for 
further evaluation after the onset of paraplegia and 
sepsis from a mid-sacral decubitus ulcer which 
further delayed his surgery. Following discharge 
from the hospital, his lack of social support 
contributed to his development of multiple 
decubitus ulcers and sepsis which eventually led to 
his death. Of note is the intramedullary location of 
his tumour, a poor prognostic indicator.
CONCLUSION
Spinal haemangioblastomas are relatively rare 
tumours. They are mostly located in the cervical and 
thoracic regions. Although benign, they can cause 
significant morbidity and even mortality. Poverty, 
ignorance and lack of social support continue to pose 
a serious challenge to the management of these 
tumours and other neurological diseases in the 
developing countries.
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